Canaccord Raises First Tracks Biotherap Price Target to $60 From $50
Canaccord Genuity maintained its Buy rating and raised its price target from $50 to $60 per share.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Canaccord Genuity maintained its Buy rating and raised its price target from $50 to $60 per share.
Oct 13 (Reuters) — Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Essex Property Trust, Qualys and Vulcan Materials on Tuesday. Highlights Essex Property Trust, Inc.: RBC cuts target price to $298 from $312 * Orion180 Insurance Group: RBC initiates co